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Abstract 
Benzoylecgonine (BE) is the most abundant metabolite of cocaine found in the 
human body. Analysis of BE in urine by gas chromatography/mass spectrometry is the 
most common method currently used to detect cocaine abuse. This current method is 
costly and time consuming, so the investigation of an easier and more cost-effective 
approach is the goal ofthis research. Because BE is a zwitterion, it is highly soluble in 
water and very difficult to extract from urine. Once the pKa values of BE are determined, 
either the cation or anion form of BE can be formed from the zwitterion by adjusting the 
pH appropriately. When BE is in a cationic or anionic state, it can be ion-paired with an 
appropriate counter-ion to form a neutral ion pair. This ion pair can then be extracted 
into a non-polar solvent, concentrated, and quantitatively determined by UV-Vis 
spectroscopy. 
The following portions of this project have been completed: BE was synthesized, 
characterized, and purity was verified. Preliminary UV-Vis spectra of BE were measured 
to determine absorption bands of BE in various solvents. Based on these preliminary 
UV-Vis spectra, dichloromethane was determined to be the best organic extracting agent. 
Next, pKa values were experimentally determined, with a PKal of2.15 +/- .01 and a pKa2 
of 11.41 +/- .01. The pH of the BE zwitterion solution was adjusted according to these 
values, and ion pairings and extractions were performed using various ions. Many ion 
pairs failed to give clear results. There has been some initial success, however, with the 
ion pair formed between BE and Dragendorfreagent, Bi4-. This ion pair was tested and 
data gathered in order to generate a clear calibration curve. 
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Introduction 
Benzoylmethylecgonine, commonly known as cocaine, is the major alkaloid of 
Erythroxylum coca. This psychotropic drug has a long history ofhuman use and, 
unfortunately, human abuse. Over 4000 years ago, people chewed coca leaves. In the 
early 1900s, cocaine was used as an ingredient in tonics and sodas I,2,3. Around this time, 
cocaine use soared and was considered safe for use by most clinicians, including 
Sigmund Freud. After its dangers became known more clearly, the use declined. 
Cocaine abuse seems to have a cyclic pattern with increasing use followed by decreasing 
use once dangers are recognized4• 
This cyclic pattern was repeated in the 1950s, 1960s, and again in the 1980s. In 
the 1980s though, cocaine was once again considered safe by abusers; it was a harmless, 
nonaddicting euphoriant. In this era, it was considered similar to marijuana and addiction 
to cocaine was dismissed. The rate of cocaine use at this time exploded. It has continued 
to be one of the more heavily used drugs up to this time. Currently the United States, as 
well as the world as a whole, is in its largest cocaine epidemic in history. One to three 
million people are estimated to be chronic cocaine abusers in this country alone4• It is 
thought that over 23 million people in America have tried cocaine5• 
Due to the large availability of cocaine across the country, the economic cost of 
its abuse is climbing. According to the National Clearinghouse for Alcohol and Drug 
Abuse, drug abuse costs for all drugs (resulting from health, crime, and other problems) 
totaled $97.7 billion dollars in 1992, and it rose to $109.8 billion in 1995. This was half 
ofthe Department ofDefense budget in that year. These numbers emphasize the 
magnitude of the drug abuse problem. There are also many noneconomic consequences 
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of serious drug abuse. Illness, crime, domestic violence, reduced productivity, and a lost 
opportunity result often from drug abuse. Cocaine related emergency episodes totaled 
over 142,000 cases in 19956. 
Cocaine is a serious problem because of its easy availability and easy use. 
Cocaine is introduced into the body in various ways, many ofwhich have arisen in the 
last 30 years. It can be introduced by intranasal entry ("snorting"), by intravenous entry 
(injecting), oral ingestion, or smoking the free base form commonly referred to as 
"crack." These methods are all equally addictive. Smoking and snorting have the added 
"bonus" ofthe same effects without the danger of infection from intravenous injection. 
Cocaine has instantaneous and overpowering effects, which enhances its popularity. 
From a study of cocaine abusers, it was reported that it generally takes about 2 to 4 years 
from the first use for a serious addiction to develop. This extended period of time before 
chronic addiction often encourages the old idea that cocaine is harmless l ,2,3,4. 
Cocaine's fundamental effect is the magnification of intensity ofmany of the 
body's normal pleasures. The surrounding environment becomes intensified without 
becoming distorted. Cocaine use enhances emotional feelings and self-confidence. Self­
perception ofmastery is also enhanced, while at the same time, anxiety is initially 
decreased. Feelings of social inhibition are reduced and feelings of interpersonal 
communication are aided. Appetite is suppressed so feelings associated with eating are 
not enhanced4• 
Cocaine addiction is believed to be a physiologic disorder. There is a need for 
some form ofmedical intervention to treat the abuse, dependence and addiction. These 
disease states are used to classify the person's need for the drug. Abuse is a level where 
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the drug use begins creating problems for the individual but control is still maintained. In 
addiction, the individual loses control. Drug dependence is a chronic disease in which 
relapse occurs frequently in abusers, which occurs after addiction begins6• In order to 
understand the problems associated with cocaine and its abuse, it is necessary to consider 
its biological basis. 
Neurochemically, cocaine acts differently than other drugs of abuse such as 
heroin, nicotine, THC(marijuana), and PCP. Unlike the others, it does not act as a 
neurotransmitter receptor. Instead, cocaine, when abused, acts by blocking the re-uptake 
ofnorepinephrine, dopamine, and serotonin, which are monoamines associated with 
memory function in the brain. The dopamine transporter is a key target or receptor for 
the effects ofcocaine, which is thought to result in the reinforcing effects of the drug. It 
is thought that the cocaine blocks the dopamine transporter stopping the reuptake of 
dopamine. Cocaine also acts as an indirect dopamine agonist. This results in build-up of 
dopamine and other monoamines in the synapses. The high concentrations of 
monoamines, especially dopamine, in the synapses result in the sought after effects: an 
increased sense of alertness, well-being, and euphoria. Unfortunately for the abuser, 
when cocaine is passed from the system, the concentration ofmonoamines in the 
synapses drops dramatically. Monoamine depletion in the presynapses results in what is 
referred to as a "crash" syndrome, or feelings ofdepression and physical discomfort. The 
only way to escape the "crash" feelings is to ingest more cocaine. This continues a 
vicious cycle of addiction: as abusers begin to "crash," they intake more and more 
cocaine2,6. 
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Once a user decides to stop abusing cocaine, a triphasic pattern of symptoms from 
abstinence results. Phase one is the crash phase. It is when the euphoric mood and 
energy vanish. Depression, anxiety, agitation, and a craving for cocaine intensify. Some 
people experience suspicion and paranoia. A craving for sleep next occurs. After sleep 
commences, the person experiences intense hypersomnolence, with 
electroencephalographic changes characteristic of sleep deprivation. Hyperphagia can 
occur in briefperiods of awakenings. 
Phase two is the withdrawal stage. When a person becomes addicted to cocaine, a 
protracted dysphoric syndrome, which includes decreased activity, causes its continued 
abuse, anxiety, lack ofmotivation, and boredom. There is markedly decreased intensity 
of normal pleasurable experiences, or anhedonia that emerges after the crash in the 
withdrawal phase. Severe cocaine cravings occur from the memories of cocaine 
euphoria4• 
Cocaine is one of the most powerful reinforcing agents because it produces 
intense classical and operant conditioning. Events previously paired with cocaine use 
induce cravings. These events are experienced as partial memories of cocaine euphoria. 
Many things can cause this triggering. They include, but are not limited to, mood states 
(both positive and negative), specific people, locations, events, times of the year, alcohol 
use, personal problems previously eased by cocaine abuse, and also tangible items 
previously associated with the abuse such as syringes, money, and pipes. Finally, stage 
three is extinction of constant cravings, but the individual is not free from addiction. 
Cravings can still emerge years after the last abuse4• 
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Along with this crash come other dangers. There are many commonly observed 
toxic side effects of cocaine. Cardiotoxicity is the most frequently observed, but central 
nervous system sensory disorders, pulmonary toxicity, and hepatotoxicity can also arise3• 
Cocaine abuse is also currently associated with the increasing AIDS epidemic in the 
country, due to needle sharing and sexual promiscuity associated with drugs of abuse5• 
Cocaine is similar to amphetamines in that it is distributed throughout the entire body 
quickly and is then cleared very rapidly. This rapid clearing had led many researchers to 
feel that one of the metabolites of cocaine may be causing the toxic effects and research 
is being conducted to establish which one exactly3. 
The horrible epidemic of cocaine abuse is spreading through the country. 
Although there has been extensive research in this area, there have been no developments 
of effective therapies for the craving associated with cocaine addiction. To begin 
isolating the problems of cocaine abuse, it is first necessary to find a way to detect the 
presence of cocaine in human abusers5• The detection ofdrugs, in this case cocaine and 
its metabolites, in biological tissues and fluids or media is an important component in 
clinical diagnosis, forensic testing, pharmacological research, and drug discovery? 
To begin work with extracting cocaine or its metabolites from any bodily fluid or media, 
many factors need to be considered. 
There are many metabolites of cocaine (Fig. 1). In 1990, Zhang et al. reported the 
finding of 11 metabolites, including four previously unreported8• Four major metabolites 
of cocaine are easily recognizable and detectable and are formed in two distinct 
biochemical processes: hydrolysis and oxidation. Enzymes within the body play 
important roles in degrading cocaine to the metabolites. Cocaine (A) in Figure 1 is 
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oxidized by specific cytochromes P450 (CYPs) and N-demethylated to fonn norcocaine 
(B). It can be further oxidized to N-hydroxy cocaine (C), a low probability metabolite, 
by oxidative metabolism. Benzoylecgonine (D) and ecgonine methyl ester (E) are 
fonned from the ester deavagelhydrolysis of cocaine by serum cholinesterases and liver 
(hepatic) carboxylesterases. Further hydrolysis of these leads to the fonnation of 
ecgonine (F), another major metabolite. Around 86-90% of an administered dose of 
cocaine is recovered in urine as cocaine or one of its metabolites. Only about 1-5% of 
this is actually cocaine. Toxicological and analytical interest in benzoylecgonine and 
ecgonine methyl ester arises from their long half-lives; in the case of benzoylecgonine, it 
is six-times longer than that of cocaine, or around 5-8 hours. Benzoylecgonine is one of 
the main degradation products, reported at 46% of the excreted metabolites, making it of 
great toxicological and analytical interest2,3. 
The study ofbenzoylecgonine is complicated by its physical properties. Its 
hydrophilic nature renders it very difficult to extract from urine into organic solvents. 
The total charge of BE, controlled by pH, allows for some control over the fonn ofBE 
that is present in the solution. Figure 2 illustrates the various fonns ofbenzoylecgonine 
that occur when pH is changed. 
The current method of detection used by laboratories that provide drug-testing 
services to employers is often a two level approach. The urine of test subjects is screened 
with an immunoassay to determine the difference between negative and positive samples. 
The initial immunoassays do have a significant false positive rate, so positive samples are 
then analyzed by gas chromatography- mass spectrometry, or GC-MS9. This method 
provides scientists with a qualitative and quantitative result. 
8 
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because the urine must be purged of excess ions and contaminants that would alter or 
influence detection ofcocaine and its metabolites. Cleanup is then followed by a 
quantitative derivatization to make the sample more volatile. All of this must occur 
before the sample is introduced into the GC-MS. This is necessary due to the fact that 
GC-MS utilizes a sample's volatility for separation and benzoylecgonine is virtually non­
volatile. In an effort to avoid the problems of this expensive and time consuming 
derivatization, researchers have been attempting to find more cost-effective and time 
saving ways to detect and quantify benzoylecgonine in urine. Other available methods of 
detection include, but are not limited to, high-performance liquid chromatography with 
ultraviolet (UV) or fluorescence detection, time-of flight (TOF), MS and liquid 
chromatography(LC)/MS. There are other analytical methods used for semi-quantitative 
screening processes such as enzyme-multiplied immunoassay, radioimmunoassay, thin­
layer chromatography (TLC), and fluorescence-polarization immunoassay. 
Because urine analysis is the most effective means in the routine detection of 
cocaine, Wallace et al. (1975) used thin-layer chromatography (TLC) to provide a rapid 
and inexpensive method to screen for cocaine in urine. The report described a screening 
technique that could separate users from non-users and that provided a sensitivity level of 
approximately 0.1 J..lglml for cocaine and 0.25 J..lglml for benzoylecgonine in the analysis 
of a 5ml urine sample. A simple extraction was performed with a mixed organic solvent 
to isolate the cocaine and metabolites from the biological medium, urine. It was reported 
that unchanged cocaine could be extracted from urine with simple organic solvents such 
as diethyl ether or chloroform. Cocaine and benzoylecgonine can also be extracted with 
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mixed solvents such as chlorofonn-isopropanol. Extractions were perfonned at moderate 
and at very alkaline pH, where BE is in its anionic fonn. For the series of extractions, a 
20% ethanol in chlorofonn mixture was utilized for both cocaine and benzoylecgonine. 
The extraction ofBE was enhanced with increasing amounts of ethanol. Wallace et at. 
also found that acid hydrolysis destroys both cocaine and its principle metabolites. They 
analyzed their extraction efficiency with gas chromatography and found that the recovery 
was 90-95% for cocaine, and 65-70% for benzoylecgonine. Because the 
benzoylecgonine metabolite predominates in in vivo specimens, they developed optimal 
chromatographic conditions for its separation and determination. The method ofTLC that 
they used seemed to increase sensitivity of detection well above previous methods lO• 
Singh et at. (1999) validated a method in which cocaine and all of its metabolites 
could be detected and quantified in rat plasma. The method used stable isotope dilution 
liquid chromatography/tandem mass spectrometry, which appeared to have yielded high 
sensitivity. The method was sensitive enough to allow, for the first time, a detailed in 
vivo study of the pharmacokinetics of cocaine and its metabolites after administration to 
rats. This method was used to overcome previous problems reported with detection of 
cocaine and its metabolites in good sensitivity. An initial relationship between cocaine 
metabolism and toxicity is being established utilizing the results ofthis study. This 
technique allowed the separation of ecgonine methyl ester, benzoylecgonine, cocaine, 
and norcocaine. This was the first experiment where ecgonine methyl ester, a very polar 
metabolite, was detected in the presence ofnorcocaine, a relatively nonpolar metabolite. 
The results of retention times and separation were highly reproducible. With this 
method, minimal sample workup was needed, and no derivatization was required3. 
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Clauwaert et al. (1996) used solid phase extractions (utilizing solid sorbents such 
as octadecylsilica), citing that due to the high hydrophilicity of benzoylecgonine, liquid­
liquid extraction solvents required an alcohol to improve extraction efficiency. These 
alcohols increase the recovery of other metabolites besides benzoylecgonine that are also 
typically present in urine. This increases chemical background noise causing interfering 
signals, and reducing the column lifetime. The solid phase extractions this group 
performed yielded satisfactory results, again with high sensitivity, specificity, and 
accuracy. Hydrolysis of cocaine and its metabolites during extraction analysis was less 
than 0.5%. This method can be applied to corroborate cocaine use, establish cocaine 
overdoses, and to study pharmacological effects of cocaine and its metabolites. Solid 
phase extractions (SPEs) have become a popular way to analyze cocaine in urine since 
they give high recovery and clean extracts. SPE, however, shows poor batch-to-batch 
reproducibility. Internal standards are needed to maintain quality ofquantitation2• 
Unfortunately, these methods are still either not quantitative enough, or still very 
expensive and time consuming. Similar to GC/MS, methodology that is based on HPLC 
and LCIMS also require heavy sample cleanup in order to obtain reasonable detection 
limits. Others, such as TOPIMS, are relatively insensitive and subject to heavy 
background noise from the biological matrix. 
In a close study of the previous literature, there is no evidence of the use of ultra­
violet/visible spectrophotometry and ion pairing for the detection and quantification of 
benzoylecgonine or cocaine metabolites. Some evidence of the use of ion pairing is 
given in Eisman et al. (1992). This paper reports the use of ion pairing and an automatic 
continuous flow method for atomic absorption of the ion-paired metal ion to detect 
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cocaine and its metabolites. This method permitted the determination of cocaine over a 
large concentration range. Metal complexes, such as Reinecke's Salt, 
{NH4[Cr(SCN)4(NH3h]} and Dragendorfreagent. [NH4Bi4], paired with cocaine, and 
were then extracted into nitrobenzene or 1,2 dichloroethane. One problem with this 
method is that it does not allow for the identification of the metabolites individually, but 
only the determination of total cocaine and cocaine metabolites, because they all retain 
the same basic structure of cocaine. However, this method does allow for the 
determination of the use of cocaine, with no pretreatment of the sample l . 
It is the purpose of this study to find a new way to detect and quantify the 
presence of cocaine and its metabolites, particularly benzoylecgonine, in urine using 
ultra-violet/visible spectrophotometry (UV-Vis). By pairing benzoylecgonine with a 
metal containing complex ionl , it would become possible to extract the hydrophilic, polar 
benzoylecgonine into a non-polar solvent. Initially the wavelength ofmaximum 
absorption for the benzoylecgonine ion pair would need to be determined. Using UV-Vis 
to compare absorption peaks in the solvent before and after extraction, the presence of 
benzoylecgonine could be detected, which would identify cocaine abuse. In order to 
quantify the BE in urine, calibrations curves could be generated with known 
concentrations ofbenzoylecgonine. The non-polar solvent ofchoice in this case is 
dichloromethane, due to cost effectiveness, and an acceptable cut-off wavelength. 
Multiple ions were tried to determine which would provide the clearest calibration curve 
with the largest amount of reproducibility. 
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Experimental 
Data Analysis Benzoylecgonine is a zwitterion, so the molecule is polar and therefore 
hydrophilic. This makes it very difficult to extract from the aqueous urine solution that is 
used in these studies. By altering the pH of the solution, the benzoylecgonine can be 
converted to either its anionic or cationic form, depending on the pH to which it is 
adjusted. There are two pKa values for benzoylecgonine and titrations were performed to 
determine both. The pKa of importance in this study is that which leads to the cationic 
form, where the amine group is protonated. The pKa values for BE were determined 
from the data obtained from the titrations. 
By measuring the pH of the benzoylecgonine at every step of the titration, it was 
possible to know the proton concentration of the solution at each point. It was also 
necessary to add a specific amount of acid (in this case HCI) to calculate the Ca, or 
analytical concentration ofbenzoylecgonine in the acid form and Cb, the analytical 
concentration of benzoylecgonine in the basic form in the solution. In order to determine 
the two PKa values, a series of calculations requiring these values need to be performed. 
The zwitterion form ofBE will be referred to as [BE-NH+-O-](Figure 2, Structure (B)). 
The deprotonated form ofBE (Figure 2, Structure C) will be referred to as [BE-N-OT, 
and the fully protonated form will be referred to as [BE-NH+-OHt (Figure 2, Structure 
D). When an acid titration is performed, Cb is [BE-NH+-0-], and Ca is [BE-NH+-OHt. 
When a base titration is performed, the Cb is [BE-N-o-r, while the Ca is [BE-NH+-0-]. 
From these values, the Ka and also pKa of the solution could be determined, using the 
following method. 
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It is necessary to proceed through a series of equations to eliminate variables. For 
benzoylecgonine, there is a proton that can be displaced, giving it the acidic form: 
(eq.l) 
In a buffered BE solution, there is also the presence of another source of BE, which 
proceeds all the way to completion. 
(eq.2) 
Water also plays a role in this reaction: 
(eq.3) 
The equilibrium expressions of these reactions are: 
Ka= [H+][BK] (eqA) 
[HBE] 
Kw=[H+][OR] (eq.5) 
The proton balance of this reaction is: 
(eq.6) 
To determine the concentrations of the acidic and basic forms ofbenzoylecgonine, 
material balance equations can be written: 
Ca=[HBE] + [BK]HBE (eq.7) 
(eq.8) 
By solving equation 6 for [BK]HBE, and substituting into equations 7 and 8, the following 
equations are obtained: 
Ca=[HBE] + [H+] -[OR] (eq.9) 
Cb=[BK]-[H+]+[OR] (eq. 10) 
By rearranging equation 5, and substituting it into equations 9 and 10, one obtains: 
(eq. 11) 
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(eq. 12) 
These two equations are then substituted into equation 4 and simplified to yield: 
Ka= [H+](Cb[H+] + [H+]2 - K~ (eq. 13) 
(Ca[H+]_[W]2 + K )w
In this equation, the [H+] can be detennined by the pH and the -log of the Ka can be 
calculated to detennine the pKa needed for the experiment. This gives a pKa for a range 
ofpoints and the average was taken for the actual pKa to use11 • 
Chemicals and Reagents 
Ecgonine methyl ester benzoate (cocaine) hydrochloride and Anhydrous (99.9%) 
dichloromethane were purchased from Acros Chemical Company. 
The following reagents were made following the procedures given in Eisman et al. 
1.	 Dragendorfreagent: A Bi(N03h5H20 (Aldrich) solution was prepared by 
dissolving 5.0 g in 10 ml of 6 M HN03. This was brought to 100 ml with 
deionized H20, the final concentration being 0.1 03M. A standard KI solution 
(3.0M) was prepared by dissolving 50 g ofKI (Sigma) into 100 ml of deionized 
H20. The carrier solution was prepared by mixing 0.4 ml of the Bi(III) solution, 
6.0 ml of standard KI solution, and 10 ml ofO.1M HCI, and bringing to volume 
with deionized water in a 100 ml volumetric flask. This yielded a solution of 4.0 
x 104 M tetraiodobismuthate(III), Bik, with a pH of2.0. 
2.	 Tetrakis(thiocyanato)cobalt(II) reagent: A standard solution of 1M was prepared 
by dissolving 29.1 g of Co(N03h6H20 (Aldrich) and 62 g ofNH4SCN (Aldrich) 
in 100 ml of deionized water. The carrier solution was made by diluting 50 ml of 
the 1M standard to 100 ml with deionized water. 
15 
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3.	 Hexakis(thiocyanato)iron(III) Solution: A 0.05M carrier solution was prepared 
by dissolving 9.2 g ofNH4SCN (Aldrich) and 2.1 g of Fe(N03h9H20 (Aldrich) 
in 100 ml of deionized water. The pH was lowered to 1.8 drop wise with 
concentrated HCl. 
4.	 Reinecke Salt (Ammonium Tetrakis(thiocyanato)diamminechromium(III), 
NH4[Cr(SCN)4NH3h.): Al% w/v solution of Reineke salt (Acros) was made in 
deionized water. 
Synthesis 
Benzoylecgonine was synthesized using a variation of the method of Stephen 
Findlay12. Cocaine hydrochloride (4.952g) was combined with excess NaHC03 solution 
(250ml). This solution was heated to boiling for approximately 30 minutes and stirred 
frequently. This formed free base cocaine. The cocaine solution was then combined with 
equal parts by volume of ether in a large separatory funnel to extract the cocaine into the 
organic layer. The aqueous layer was then separated and re-extracted a total of 5 times. 
The organic layer was saved during this time, and then placed on a roto-evaporator until 
it was dry. To convert cocaine to benzoylecgonine (hydrolysis reaction), the precipitate 
was dissolved in H20 and the placed on the rotovap until it was partially dry. The 
benzoylecgonine precipitated, was filtered, and was further dried over P20S (3.967g, 
80.1 %). 
16
 
•
 
Procedure
 
pKa determination for benzoylecgonine:
 
An approximate O.OlM HCl solution was prepared and standardized by titration 
using phenolphthalein as an indicator. It was titrated against a KHP standardized 
0.0135M NaOH solution. The titration was repeated in triplicate and the average of the 
three trials was used. 
The potentiometric (PH) titrations for BE were performed using a 0.00352lM 
benzoylecgonine solution. The BE solution (lOrnI) was titrated with the standardized HCl 
using a pH meter placed in the solution. A micropipetter was used to deliver 0.100 ml of 
HCI and the pH meter was read after each addition. The titrations with HCl were 
repeated and following accurate replication, the process was repeated with standardized 
NaOH. 
Extraction of benzoylecgonine/ion complex with dichloromethane: 
Before calibration curves were generated, many ions pairs were tested to 
determine if they did indeed pair well with BE, making it easier to be extracted into an 
organic phase. 
A stock solution ofbenzoylecgonine was prepared by adding 0.497lg of 
benzoylecgonine to 100mi of deionized water (0.0017M). Standard BE solutions were 
prepared by serial dilutions. Solutions of9.942ppm(-lOppm), 0.9942ppm (-lppm), 
29.826ppm(-30ppm), and 2.9826ppm(-3ppm) were prepared. 
Initial extractions were performed by the following protocol: 5ml of a BE stock 
solution was mixed with 5ml of the carrier solution. The pH was lowered to -2, where 
BE would be in the cationic form. The BE/ion complex was extracted with 5ml of 
17 
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dichloromethane. The dichloromethane containing the neutral BE/ion complex was then 
analyzed using UV-Vis spectrophotometry. Dichloromethane blanks and deionized water 
blanks were analyzed for comparison with every ion. The aqueous layer was run for one 
trial before and after extraction to ensure that BE was being extracted. The solution was 
diluted until readable values were obtained within detection limits of the instrument. The 
cutoff wavelength of235nm was used. 
An alteration of the previous method was used for Dragendorfreagent. For Bik, 
the sample pH of BE was lowered to be 3.0. The carrier, or metal complex ion, pH was 
adjusted to 2.0. A 4xl04M solution ofDragendorf reagent was used1• The initial 
protocol was altered so that only 2 ml of carrier solution was used for ion pairing. The 
yellow carrier solution was mixed with the clear BE solution and then the extraction was 
performed. Upon addition of dichloromethane, the solution turned pink. With higher 
concentrations of BE, the solution appeared more orange. 
18
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Using IR, NMR, GC/MS, and melting point determination, the synthesized 
benzoylecgonine was analyzed for purity. The melting point was determined at 140­
15SoC. No melting point data are available in the literature. The percent yield of 
benzoylecgonine (3.967g) calculated from the mass of cocaine hydrochloride (4.952g) 
used was SO.l %. 
Infrared spectra obtained were compared to literature spectra12• There are similar 
peaks between the spectra. In Figure 3, the presence ofa large carbonyl peak (at1727 cm­
I spectrum resembles the data in the literature12• Many of the peaks are very close to 
what are expected in the structure. The peak at 3426 em-I may result from impurities. It 
could correspond to a peak from various other metabolites, including N-hydroxy cocaine, 
which would show an N-OH peak, or norcocaine, which would show an N-H tertiary 
amine peak. (See Figure 1 for structures). This peak is not obvious in the literature 
structure, suggesting that there were some impurities in the BE synthesized. This is 
further supported by the GC data. 
Following JR, IH NMR spectra were obtained. Figure 4 has peaks for each of the 
protons in the structure ofBE. The two hydrogen peaks from the aromatic ring are 
located at 7.3 and 7.9 ppm. The large peak at 2.4 ppm corresponds to the three protons 
located in the N-CH3 group. The remainder of the protons from the nitrogen-containing 
ring are located to the right of the large peak at 2.4 ppm in the mass of peaks. The peak 
labeled HB has more than one proton, lending more support to impurities in the product. 
Even with an extensive literature search, no literature spectra have been found. This 
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makes it much more difficult to analyze correctly and compare the spectra, but provides 
basis for new explorations in benzoylecgonine. 
The B C NMR, Figure 5, has characteristic carbon peaks for each of the two 
carbonyls, located at 166 and 173 ppm. It also has peaks at 128-133 ppm (corresponding 
to aromatic carbons). The alkane peaks occur at 24, 26,34,38,48, and 61 ppm. These 
are the carbons located in the amine ring. The two peaks at 64 and 65 ppm are the peaks 
for the N-C and o-c carbons. To identify which of these carbon shifts pertains to 
specifically which carbon, a coupled I3C NMR would need to be run. In the coupled 
spectra, the carbon bonded to the nitrogen would show up as a quartet, while the C-O-C 
would show up as a doublet. This could allow assignment of the exact carbon peak 
assignments. 
GC/MS was used to further verify that the product synthesized was actually BE 
and not one of the other major metabolites. These spectra identified impurities in the 
product to be unreacted cocaine, which would not give the peak identified in the IR 
spectra, but another metabolite would. As visualized by the chromatogram, BE was the 
primary product in the reaction. The peaks of the mass spectrum can be identified as 
component parts of BE (Figure 6), with the largest mass-to-charge peak matching that of 
BE itself. Purity ofbenzoylecgonine was determined by gas chromatography to be 
94.3%. This was an acceptable purity because cocaine metabolites in natural systems are 
always a mixture ofbenzoylecgonine and other metabolites. This product resembles that 
of natural systems more closely due to the impurities. The goal of this study is detection 
of cocaine and its metabolites; whichever one we detect is still a positive test. No 
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attempts to purify further were made. Additional purification would have been more 
helpful for NMR and IR characterization. 
Once the BE was correctly synthesized and characterized, the pKa values were 
determined by titration. The standardized HCI was 0.0112M as determined by titrations 
with KHP and standardized NaOH (0.01351M). To isolate BE in an environment where 
it is a charged molecule, the pKa values were obtained experimentally by titration with 
both HCI and NaOH. Other laboratory members performed the series ofNaOH titrations. 
Figure 7, plotted as pH versus equivalents of BE shows the results of those titrations. 
Equation 13 was used to determine the pKa. Final values obtained were a 
pKal=2.15±0.01 and pKa2 =11.41±0.01. The lower pKa value is utilized in this study, for 
the reason that below that pKa value, BE is in its cationic form where the amine group is 
protonated. This positive ion can then be paired with a negative carrier ion to form the 
neutral ion pair, which can further be extracted into an organic, non-polar solvent. 
In order to determine the solvent that worked best under the conditions of this 
study, preliminary UV-Visible spectra were obtained to determine absorption bands of 
BE in various solvents. Based on these spectra, dichloromethane was determined to be 
the best organic extracting agent. The molar absorptivity ofbenzoylecgonine in 
dichloromethane was 0.0796 at 217.00nm. Another key aspect of dichloromethane was 
that BE was readily soluble in it, in comparison to some of the other attempted solvents, 
such as benzene. 
Once the solvent was chosen, it was necessary to find a carrier solution that could 
quickly and accurately pair with the BE. A high sensitivity was the goal. Selectivity of 
BE over other metabolites was not considered an issue. After initial trials with various 
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metal complexes by previous group members, the ion pairs ofEisman et al. (1992)1 were 
utilized for this study. The ability of the benzoylecgonine to form ion pairs with the 
ligand complexes (in this case Co, Fe, Cr, or Bi) occurred by the action of the nitrogen 
atom. The nitrogen of the benzoylecgonine was protonated in the acidic media, which 
would aid in the formation of the ion pair with the negative metal complex1• 
Initial tests with Co(SCN)l- showed that it was not ideal for detecting BE in 
solution effectively. Variable results were obtained, with little or no repeatability. 
Because it is a divalent anion, Co(SCN)l forms a 2:1 complex with cocaine and its 
metabolites, which may pose a problem with forming as many neutral complexes as 
might be possible with a 1:1 complex. This lack of forming neutral complexes could 
have hindered the efficient and repeatable extractions ofBE into an organic layer. 
Absorption ofunpaired tetrakis(thiocyanato)cobalt(II) extracted with 
dichloromethane is 0.9221 absorption units at 243.00 nm. Absorption of the ion pair 
between tetrakis(thiocyanato)cobalt(II) and BE is 0.7147 absorption units at 242.00nm. 
This shows a decreasing absorbance with addition ofBE. In this case, the unpaired 
carrier ion was doing the absorbing, and upon complexation with BE, it no longer 
absorbed, which led to the decrease in absorbance when BE was added. Even with 
alterations of extractions, the absorbance continued to decrease. A linear, increasing 
relationship between the formation of the ion pair and the concentration ofBE present 
was the goal. 
Reinecke Salt as an ion pair was also lacking in repeatability and a smooth 
calibration curve. Previous trials ofother laboratory members offered more satisfactory 
results than this study. Reinecke Salt had problems associated with its study in that it 
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was difficult to keep in solution. The stock solution had to be made fresh daily due to 
settling problems when it was allowed to sit, and cost effectiveness was very important in 
this study. It did not appear to be completely soluble at the concentrations utilized by 
previous studies!. Preliminary tests ruled it out as a possibility after multiple trials and 
pH tests were performed. The pH of both the ion and the benzoylecgonine solutions were 
raised and lowered in various trials, but nothing improved the repeatability of the ion and 
extractions. The best circumstances for extraction with Reinecke Salt were obtained 
from the literature!, with a benzoylecgonine sample pH ofaround 1.0 in the range of 0.3­
2.5, and a carrier solution pH of4.7 in the range of 2.8-6.2. Even with the optimal pH 
used in the study, the closest to a smooth linear curve is shown in Figure 8. There were 
problems in the lower concentrations ofbenzoylecgonine in that the ion often did not 
extract efficiently. Reinecke Salt was found in the literature to be one of the least 
sensitive ions to pair with cocaine or any of its metabolites, which corresponds to the 
results found in this study!. Molar absorptivity values of the ion pair between Reinecke 
Salt and BE are located in Table 1. 
After trials with Reinecke salt, investigation of the Fe(SCN)63-complex began. In 
many trials, the pH ofboth the benzoylecgonine and the Fe(SCN)/ ion were altered to 
attempt to find an ideal environment for the extractions. This complex forms a 3: 1 
complex with cocaine and its metabolites. This decreases its sensitivity to cocaine or its 
metabolites due to the fact that three BE ions need to bind to each metal complex ion!. It 
also had decreasing absorbance peaks with increasing concentrations. The decrease was 
not linear, so the calibration curve generated was not usable. An attempt at a calibration 
curve was made, after initial tests seemed to have positive results. Unfortunately, as 
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more and more tests were performed, the results became increasingly inconclusive. 
Figure 9 portrays the three best trial runs with the Fe(SCN)/ ion. As visualized by the 
figure, these tests were not repeatable enough to be useful. 
For Dragendorfreagent, or Bik, variable concentrations ofBE were used. In 
literature studies, IO~glml was used, which is equivalent to the 10ppm sample in this 
study. In previous studies, Dragendorfreagent was shown to have the highest sensitivity 
to cocaine and its metabolites. It forms an ion pair of 1:1 with BE, cocaine, or other 
metabolites. The ion pair between benzoylecgonine and Dragendorf reagent is shown in 
Figure 10. It does have a lower selectivity in that other alkaloids present would bind as 
well as cocaine or BE. It is optimal though because a lower inorganic layer concentration 
provides for better formation of ion pairs and improved extraction l . In this study, the 
carrier ion was always in excess of the BE to ensure that all possible BE was paired and 
then extracted. For Dragendorf reagent, when extracted with dichloromethane, it turns 
the dichloromethane from colorless to pink. In the presence ofBE, it turns slightly 
orange, more so with increasing concentrations. 
Figure 11 shows initial UV-Vis trials. As seen in the figure, the peak at 367 nm 
increases with increasing BE concentrations. There is also a characteristic orange color of 
the solution that increases with the increase of this peak. It is thought to be due to the 
increasing presence of the ion pair in the dichloromethane. In addition to the peak at 367 
nm, there are two other peaks in the UV-Vis spectra. The peak at 260 nm is 
characteristic ofbenzene containing compounds, such as benzoylecgonine. It increased 
drastically when BE was not fully paired with Dragendorf reagent. The other peak 
present on the spectra is the one at around 500 nm. It remains constant with increasing 
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concentrations of BE, leading to the conclusion that it is caused by Dragendorf reagent, 
whose concentration was held constant throughout trials. 
The linear increase between BE concentrations and absorbance occurs at the peak 
of 367 run in Figure 11. After many trials and varying pH of solutions, the protocol for 
this ion was generated that allowed for optimal extraction and optimal sensitivity of 
Dragendorf reagent to BE. A calibration curve was generated with a fairly linear 
increase. In figure 12, the beginning ofa calibration curve is portrayed. It shows each of 
the trials individually. These trials were then averaged to give a final calibration curve 
for the ion pair between Dragendorf reagent and benzoylecgonine. 
Figure 13 shows the final calibration curve with Dragendorf reagent. The blue 
line on the graph represents the average calibration curve for all points on the graph. 
There is a source of error in that the final point seems nonlinear with the initial 4 points. 
The standard error of the slope is 6.91 %. The red line on the graph is the calibration 
curve if the final point is removed. The standard error decreases to 3.71% and the points 
all lie close to the final line. The R2 value for this graph is 0.9972. There are many 
reasons to feel that the final point is too variable for the calibration curve. The point is 
reaching the absorbance limits of the instrument at almost 2. There seems to be a 
limitation in this method in that it cannot detect above -2Oppm. Further trials need to be 
performed to test the range between 10 and 30 ppm. The low end of the concentration 
range also needs to be tested in order to develop or measure the limit of detection. 
A large benefit ofDragendorfreagent is its sensitivity. In comparing data 
obtained of the other ions tried and for Dragendorf reagent, Dragendorf reagent had 
molar absorptivity values an order of magnitude greater than the other ions (Table 1). 
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This is obvious in comparison of the two calibration curves generated, that ofhexakis 
(thiocyanato)iron III! BE ion pair and that of the Dragendorfreagent/BE ion pair. The 
calibration curve ofhexakis (thiocyanato)iron III! BE ion pair had a molar absorptivity of 
0.0027 M/cm in comparison to the molar absorptivity of the Dragendorfreagent/BE ion 
pair was almost 10 times that at 0.07838 M/cm (Table 1). This is very important for 
sensitivity, especially in the lower concentrations of BE. The lower concentrations ofBE 
most resemble those that could be found in urine of test subjects, so sensitivity at these 
levels is extremely important. 
This study successfully generated a new possible method to detect and quantify 
the presence of BE in urine. Dragendorf reagent has provided a sensitive and cost 
efficient method to replace or, at the very least, supplement current tests. It provides a 
very simplistic approach to detecting cocaine and its metabolites in urine. Although there 
are slight limitations in its upper range, it remains a qualitative test at these higher values. 
The major area of sensitivity though, that of the lower concentrations of 1-10 ppm BE, is 
the most important, especially because it is very quantitative at these values. This is the 
range where most concentrations of BE in urine will fall, and this is the area where 
Dragendorf reagent performs the best. Further experimentation does need to occur to 
solidify this data, but this study shows a start towards finding a more cost efficient 
method of detecting and quantifying benzoylecgonine in urine. 
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Table 1 
Carrier Ion Molar Absorptivity,(, (M/em) 
Draaendorf Reagent 0.07838 
Reinecke Salt 0.0061 
Hexakis (Thioncyanato)iron(lll) 0.0027 
Figure 1. Cocaine and its primary metabolites 
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Figure 7Benzoylecgonine Titration Curve 
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